1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow JV-394: new trials by email Literature Review of JV-394 trials Research Report on JV-394
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms JV-394 - Neoplasms | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 33 | 2026-02-18 | 2026-08-12 |
Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, T-Cell (1) · Neoplasms (1)
M.D. Anderson Cancer Center (1)
United States (1)